Any D-galactoside having beta-configuration at its anomeric centre.
ChEBI ID: 28034
| Member | Definition | Role |
|---|---|---|
| 4-methylumbelliferyl-galactopyranoside | A beta-D-galactoside having a 4-methylumbelliferyl substituent at the anomeric position. | 4-methylumbelliferyl beta-D-galactoside |
| 4-nitrophenylgalactoside | A beta-D-galactopyranoside having a 4-nitrophenyl substituent at the anomeric position. | 4-nitrophenyl-beta-D-galactoside |
| 5-bromo-4-chloro-3-indolyl beta-galactoside | An indolyl carbohydrate that is the beta-D-galactoside of 3-hydroxy-1H-indole in which the indole moiety is substituted at positions 4 and 5 by chlorine and bromine, respectively. It is used to test for the presence of an enzyme, beta-galactosidase, which cleaved the glycosidic bond to give 5-bromo-4-chloro-3-hydroxy-1H-indole, which immediately dimerises to give an intensely blue product. | 5-bromo-4-chloro-3-indolyl beta-D-galactoside |
| 6-bromo-2-naphthyl-beta-galactopyranoside | A beta-D-galactoside having a 6-bromo-2-naphthyl substituent at the anomeric position. | 6-bromo-2-naphthyl beta-D-galactoside |
| hyperoside | A quercetin O-glycoside that is quercetin with a beta-D-galactosyl residue attached at position 3. Isolated from Artemisia capillaris, it exhibits hepatoprotective activity. | quercetin 3-O-beta-D-galactopyranoside |
| isorhamnetin-3-o-galactoside | A glycosyloxyflavone that is isorhamnetin substituted at position 3 by a beta-D-galactosyl residue. | isorhamnetin 3-O-beta-D-galactopyranoside |
| kaempferol-3-o-galactoside | A beta-D-galactoside compound with a 4',5,7-trihydroxychromen-3-yl group at the anomeric position. | kaempferol 3-O-beta-D-galactoside |
| methyl beta-galactoside | A beta-D-galactopyranoside having a methyl substituent at the anomeric position. | methyl beta-D-galactoside |
| nitrophenylgalactosides | A beta-D-galactoside having a 2-nitrophenyl substituent at the anomeric position. | 2-nitrophenyl beta-D-galactoside |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 144 (12.05) | 18.7374 |
| 1990's | 204 (17.07) | 18.2507 |
| 2000's | 345 (28.87) | 29.6817 |
| 2010's | 397 (33.22) | 24.3611 |
| 2020's | 105 (8.79) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (0.07%) | 5.53% |
| Reviews | 14 (1.04%) | 6.00% |
| Case Studies | 3 (0.22%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 1,328 (98.66%) | 84.16% |